Search Results

You are looking at 31 - 40 of 2,686 items for :

  • Refine by Access: All x
Clear All
Full access

New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients

Neel K. Gupta and Charalambos Andreadis

journal CE activity: 1) review the learning objectives and author disclosures; 2) study the education content; 3) take the posttest with a 66% minimum passing score and complete the evaluation at http://education.nccn.org/node/54139 ; and 4) view

Full access

QIM19-139: Reflex Testing of Oncotype DX Recurrence Score: A Single Institution Review of a Quality Improvement Protocol

Mara A. Piltin, Kathryn Eckert, Margaret Wight, Alan J. Shienbaum, Jeanine Chiffarano, Trina A. Poretta, Tamara A. LaCouture, Monica N. Khattak, Michele E. Gaguski, Alyssa Imperatore, Sruti Golthi, and Kahyun Yoon-Flannery

continue to evolve, particularly with the use of genomic assays. Our single institution review confirms the utility of our reflex Oncotype DX protocol with a decreased time to result with reflex testing of patients in the appropriate clinical setting

Full access

QIM19-121: Improving Testing for Hepatitis B Before Treatment With Rituximab Through Automated Electronic Health Record Alert System: A Single Institutional Retrospective Review and Quality Improvement Project

Sowmya Boddhula, Satish Kumar Boddhula, Bishesh Shrestha, Kelly Morris, and Rosana Gnanajothy

of chemotherapy with RTX and results the previously resulted HBV test results. Retrospective data analysis for screening was done after implementation of the software and its impact was assessed. Methods: We conducted retrospective chart review on

Full access

Screening for Lung Cancer: An Expert Review

Presented by: Ella A. Kazerooni, Jacob Sands, and Douglas E. Wood

Cancer Screening Panel, reviewed current evidence for and preferred modalities of lung cancer screening and identified patients at high risk who would be appropriate for such screening. The presenters also discussed current challenges regarding the use of

Full access

Management of Recurrent Small Cell Lung Cancer

Bryan J. Schneider

Small cell lung cancer remains one of the more frustrating malignancies for oncologists to treat. Although responses to initial platinum-based chemotherapy are high, most are not durable, and many patients are candidates for further palliative chemotherapy. Therapeutic options include reinduction or single-agent chemotherapy, depending on the duration of response to front-line treatment. Topotecan is the only approved agent for patients with relapsed disease. Several phase II studies have shown a modest benefit with other agents used today, although combination chemotherapy should be avoided because of increased toxicity. Palliative care should always be the focus, especially in patients with recurrent or chemorefractory small cell lung cancer and a poor performance status.

Full access

Creating an Effort Tracking Tool to Improve Therapeutic Cancer Clinical Trials Workload Management and Budgeting

Pam James, Patty Bebee, Linda Beekman, David Browning, Mathew Innes, Jeannie Kain, Theresa Royce-Westcott, and Marcy Waldinger

requirement, some data managers categorized this communication into a general “other, specify” category rather than a more specific category, such as “patient enrollment.” Regular review of the information being entered into RETA was required at the outset to

Full access

EPR19-74: Risk of Cabozantinib-Associated Gastrointestinal and Hepatic Toxicities in Patients With Metastatic Solid Tumors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Anita Sultan, Sriman Swarup, Francis Mogollon-Duffo, Ye Aung, Yin M. Myat, Myo H. Zaw, Rachana Yendala, Nicholas D’Cunha, and Kyaw Z. Thein

. These pathways are implicated in several tumor development and progression. We performed a systematic review and meta-analysis of randomized controlled trials (RCT) to determine the risk of gastrointestinal (GI) and hepatic toxicities among patients with

Full access

A Brief Review of Pharmacotherapies for Smoking Cessation

Cho Y. Lam, Jennifer A. Minnix, Jason D. Robinson, and Paul M. Cinciripini

nicotine patch: a randomized controlled trial . Addiction 2004 ; 99 : 634 – 640 . 25. Perkins K . Response to Dar and Frenk 2004, ``Do smokers self-administer pure nicotine? A Review of the evidence'' . Psychopharmacology Berl 2004 ; 175

Full access

The Economic Impact of Non-Melanoma Skin Cancer: A Review

Tejaswi Mudigonda, Daniel J. Pearce, Brad A. Yentzer, Phillip Williford, and Steven R. Feldman

settings and different physician groups involved, and evaluating results of recent studies comparing the cost of different treatment modalities with respect to procedure type, tumor size, and tumor location. Analysis and review of the current literature on

Full access

Small Cell Lung Cancer in Elderly Patients: A Review

Taofeek K. Owonikoko and Suresh Ramalingam

Vougiouka M . Cisplatin and platinum drugs at the molecular level [review] . Oncol Rep 2003 ; 10 : 1663 – 1682 . 18. Skarlos DV Samantas E Kosmidis P . Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in